Showing 21 - 40 results of 94 for search '"respiratory syncytial virus"', query time: 0.09s Refine Results
  1. 21
  2. 22

    A Cross-Study Biomarker Signature of Human Bronchial Epithelial Cells Infected with Respiratory Syncytial Virus by Luiz Gustavo Gardinassi

    Published 2016-01-01
    “…Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, elderly, and immunocompromised individuals. …”
    Get full text
    Article
  3. 23

    Clinical Epidemiological Characteristics and Risk Factors for Severe Bronchiolitis Caused by Respiratory Syncytial Virus in Vietnamese Children by Sang Ngoc Nguyen, Thuy Ngoc Thi Nguyen, Lam Tung Vu, Thap Duc Nguyen

    Published 2021-01-01
    “…The disease is caused by respiratory syncytial virus (RSV) infection, which can cause breathing difficulties and respiratory failure. …”
    Get full text
    Article
  4. 24

    Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases by Elliott J. Carande, Andrew J. Pollard, Simon B. Drysdale

    Published 2016-01-01
    “…In 1995, the European Society for Paediatric Infectious Diseases (ESPID) carried out a survey of its members to assess the variation in management of respiratory syncytial virus (RSV) bronchiolitis. The aim of the current study was to carry out a similar survey 20 years later to assess how the management had changed. …”
    Get full text
    Article
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    Inhibition of NF-κB/IL-33/ST2 Axis Ameliorates Acute Bronchiolitis Induced by Respiratory Syncytial Virus by Liwen Zhang, Yu Wan, Liang Ma, Kaihong Xu, Baojin Cheng

    Published 2021-01-01
    “…Bronchiolitis is a common acute lower respiratory tract infectious disease in infants. Respiratory syncytial virus (RSV) infection is one of the main causes. …”
    Get full text
    Article
  11. 31
  12. 32

    Respiratory Syncytial Virus Nonstructural Protein 1 Promotes 5-Lipoxygenase via miR-19a-3p by Mei Zheng, Panpan Fan, Pu Yang, Junwen Zheng, Dongchi Zhao

    Published 2022-01-01
    “…Background. Respiratory syncytial virus (RSV) infection can regulate the expression of a wide range of noncoding microRNAs (miRNAs), in which mir-19a-3p can participate in airway inflammatory response by regulating 5-lipoxygenase (5-LO) pathway. …”
    Get full text
    Article
  13. 33
  14. 34

    A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus by Min Lin, Yifan Yin, Xiaomeng Zhao, Chen Wang, Xueqing Zhu, Letao Zhan, Li Chen, Siling Wang, Xue Lin, Jun Zhang, Ningshao Xia, Zizheng Zheng

    Published 2025-02-01
    “…Abstract The Food and Drug Administration (FDA) has approved vaccines designed by GSK, Pfizer and Moderna to protect high-risk populations against respiratory syncytial virus (RSV). These vaccines employ the pre-fusion F (pre-F) protein as the immunogen. …”
    Get full text
    Article
  15. 35

    Impact of COVID-19 on testing, positive cases, patient characteristics, and hospital contacts for respiratory syncytial virus, influenza, and pneumococcus in Danish children by Andreas Jensen, Lone Graff Stensballe

    Published 2025-02-01
    “…Results: We observed a marked decrease in cases of respiratory syncytial virus, influenza, and pneumococcus disease during the lockdown period. …”
    Get full text
    Article
  16. 36
  17. 37
  18. 38

    Cross-sectional seroprevalence study of bovine herpesvirus 1, bovine respiratory syncytial virus, and parainfluenza virus 3 in cattle from Villavicencio, Colombia by Catalina Ballesteros González, Karen Briñez, Julio César Tobón, Danny Wilson Sanjuanelo Corredor, Fernando Vicosa Bauermann, Blanca Lisseth Guzmán Barragán

    Published 2025-01-01
    “…Many viruses are considered causative agents of BRDC, including bovine herpesvirus 1 (BoHV-1), bovine respiratory syncytial virus (BRSV), and parainfluenza virus 3 (PI-3). …”
    Get full text
    Article
  19. 39
  20. 40

    An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease by Jianglong Li, Haiyan Long, Shaoyi Chen, Zhendong Zhang, Shuang Li, Qi Liu, Jun Liu, Jiaru Cai, Liping Luo, Yucai Peng

    Published 2025-01-01
    “…Background: Respiratory syncytial virus (RSV) causes the most common type of severe lower respiratory tract infection worldwide, and the fusion (F) protein is a target for neutralizing antibodies and vaccine development. …”
    Get full text
    Article